Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · see citing works

Parkinson's disease

Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,412 · see citing works

α-Synuclein Locus Triplication Causes Parkinson's Disease

Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383 · see citing works

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · see citing works

Circulating mitochondrial DAMPs cause inflammatory responses to injury

Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812 · see citing works

Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology

Zimprich, A. A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M. J., Lincoln, S., Kachergus, J. M., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,024 · see citing works

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990 · see citing works

Genome-wide association studies for complex traits: consensus, uncertainty and challenges

McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891 · see citing works

An Essay on the Shaking Palsy

Parkinson, J. (2002) · Journal of Neuropsychiatry · doi:10.1176/jnp.14.2.223 · Cited by 2,684 · see citing works

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593 · see citing works

Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model

Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208 · see citing works

Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135 · see citing works

Genome-wide association study reveals genetic risk underlying Parkinson's disease

Simón‐Sánchez, J., Schulte, C., Brás, J., Sharma, M., Gibbs, J. R., Berg, D., Paisán‐Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,916 · see citing works

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease

International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895 · see citing works

On the origin of mitosing cells

Sagan, L. (1967) · Journal of Theoretical Biology · doi:10.1016/0022-5193(67)90079-3 · Cited by 1,870 · see citing works

Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin

Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · see citing works

Tlr signalling augments macrophage bactericidal activity through mitochondrial ros

West, A. P., Brodsky, I. E., Rahner, C., Woo, D. K., Erdjument-Bromage, H., Tempst, P., Walsh, M. C., Choi, Y., Shadel, G. S., & Ghosh, S. (2011) · Nature · doi:10.1038/nature09973 · Cited by 1,659 · see citing works

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein

Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485 · see citing works

Mitochondria in innate immune responses

West, A. P., Shadel, G. S., & Ghosh, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri2975 · Cited by 1,376 · see citing works

Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies

Mazzulli, J. R., Xu, Y.-H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., & Krainc, D. (2011) · Cell · doi:10.1016/j.cell.2011.06.001 · Cited by 1,341 · see citing works

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.485 · Cited by 1,308 · see citing works

Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity

West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507360102 · Cited by 1,228 · see citing works

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1884 · Cited by 1,208 · see citing works

Mitochondrial pathology and apoptotic muscle degeneration in <i>Drosophila parkin</i> mutants

Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737556100 · Cited by 1,203 · see citing works

Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention

Tansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045 · see citing works

Genomewide Association Study of Leprosy

Zhang, F., Huang, W., Chen, S., Sun, L., Liu, H. D., Li, Y., Cui, Y., Yan, X., Yang, H., Yang, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903753 · Cited by 1,037 · see citing works

Differential Regulation of Dynein and Kinesin Motor Proteins by Tau

Dixit, R., Ross, J. L., Goldman, Y. E., & Holzbaur, E. L. F. (2008) · Science · doi:10.1126/science.1152993 · Cited by 1,012 · see citing works

Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice

Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401135200 · Cited by 995 · see citing works

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies

Nalls, M., Plagnol, V., Hernandez, D., Sharma, M., Sheerin, U., Saad, M., Simón-Sánchez, J., Schulte, C., Lesage, S., Sveinbjörnsdóttir, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62345-8 · Cited by 986 · see citing works

Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

Kim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856 · see citing works

Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates

Lee, H.-J., Patel, S. S., & Lee, S. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0692-05.2005 · Cited by 798 · see citing works

Mapping of a gene for Parkinson's disease to chromosome 4q21-q23

Polymeropoulos, M. H., Higgins, J. J., Golbe, L. I., Johnson, W. G., Ide, S. E., Di Iorio, G., Sanges, G., Stenroos, E. S., Pho, L. T., Schaffer, A. A., et al. (1996) · Science · doi:10.1126/science.274.5290.1197 · Cited by 788 · see citing works

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease

Hamza, T. H., Zabetian, C. P., Tenesa, A., Laederach, A., Montimurro, J. S., Yearout, D., Kay, D. M., Doheny, K. F., Paschall, J. E., Pugh, E., et al. (2010) · Nature Genetics · doi:10.1038/ng.642 · Cited by 779 · see citing works

Meta‐analysis of early nonmotor features and risk factors for Parkinson disease

Noyce, A. J., Bestwick, J. P., Silveira‐Moriyama, L., Hawkes, C. H., Giovannoni, G., Lees, A. J., & Schrag, A. E. (2012) · Annals of Neurology · doi:10.1002/ana.23687 · Cited by 772 · see citing works

Genetics of Parkinson disease: paradigm shifts and future prospects

Farrer, M. J. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1831 · Cited by 709 · see citing works

Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications

Farrer, M. J., Kachergus, J. M., Forno, L. S., Lincoln, S., Wang, D., Hulihan, M., Maraganore, D. M., Gwinn, K. A., Wszołek, Z. K., Dickson, D. W., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10846 · Cited by 699 · see citing works

Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia

Fellner, L., Irschick, R., Schanda, K., Reindl, M., Klimaschewski, L., Poewe, W., Wenning, G. K., & Stefanova, N. (2013) · Glia · doi:10.1002/glia.22437 · Cited by 697 · see citing works

Kinase activity of mutant LRRK2 mediates neuronal toxicity

Smith, W. W., Pei, Z., Jiang, H., Dawson, V. L., Dawson, T. M., & Ross, C. A. (2006) · Nature Neuroscience · doi:10.1038/nn1776 · Cited by 619 · see citing works

What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease

Corti, O., Lesage, S., & Brice, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00022.2010 · Cited by 610 · see citing works

Designing Genome-Wide Association Studies: Sample Size, Power, Imputation, and the Choice of Genotyping Chip

Spencer, C. C. A., Su, Z., Donnelly, P., & Marchini, J. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000477 · Cited by 606 · see citing works

Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

PSP Genetics Study Group, Höglinger, G. U., Melhem, N. M., Dickson, D. W., Sleiman, P. M. A., Wang, L.-S., Klei, L., Rademakers, R., de Silva, R., Litvan, I., et al. (2011) · Nature Genetics · doi:10.1038/ng.859 · Cited by 603 · see citing works

The ubiquitin ligase parkin mediates resistance to intracellular pathogens

Manzanillo, P. S., Ayres, J. S., Watson, R. O., Collins, A. C., Souza, G., Rae, C. S., Schneider, D. S., Nakamura, K., Shiloh, M. U., & Cox, J. S. (2013) · Nature · doi:10.1038/nature12566 · Cited by 588 · see citing works

The link between the GBA gene and parkinsonism

Sidransky, E., & Lopez, G. J. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70190-4 · Cited by 575 · see citing works

Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway

Li, Y., Liu, L., Barger, S. W., & Griffin, W. S. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01605.2003 · Cited by 563 · see citing works

The Familial Parkinsonism Gene LRRK2 Regulates Neurite Process Morphology

MacLeod, D., Dowman, J., Hammond, R., Leete, T., Inoue, K., & Abeliovich, A. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.008 · Cited by 561 · see citing works

Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains

Alvarez‐Erviti, L., Rodríguez-Oroz, M. C., Cooper, J. A. D., Caballero, C., Ferrer, I., Obeso, J. A., & Schapira, A. H. V. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.198 · Cited by 550 · see citing works

LIMP-2 Is a Receptor for Lysosomal Mannose-6-Phosphate-Independent Targeting of β-Glucocerebrosidase

Reczek, D., Schwake, M., Schröder, J., Hughes, H., Blanz, J., Jin, X., Brondyk, W. H., Patten, S. V., Edmunds, T., & Säftig, P. (2007) · Cell · doi:10.1016/j.cell.2007.10.018 · Cited by 544 · see citing works

Identification of a Novel LRRK2 Mutation Linked to Autosomal Dominant Parkinsonism: Evidence of a Common Founder across European Populations

Kachergus, J. M., Mata, I. F., Hulihan, M., Taylor, J. P., Lincoln, S., Aasly, J. O., Gibson, J. M., Ross, O. A., Lynch, T., Wiley, J. C., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429256 · Cited by 536 · see citing works

α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity

Gitler, A. D., Chesi, A., Geddie, M. L., Strathearn, K. E., Hamamichi, S., Hill, K. J., Caldwell, K. A., Caldwell, G. A., Cooper, A. A., Rochet, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.300 · Cited by 535 · see citing works

Scavenger receptor B2 is a cellular receptor for enterovirus 71

Yamayoshi, S., Yamashita, Y., Li, J., Hanagata, N., Minowa, T., Takemura, T., & Koike, S. (2009) · Nature Medicine · doi:10.1038/nm.1992 · Cited by 519 · see citing works

RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk

MacLeod, D. A., Rhinn, H., Kuwahara, T., Zolin, A., Paolo, G. D., McCabe, B. D., Marder, K. S., Honig, L. S., Clark, L. N., Small, S. A., et al. (2013) · Neuron · doi:10.1016/j.neuron.2012.11.033 · Cited by 519 · see citing works

Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson’s disease

Do, C. B., Tung, J. Y., Dorfman, E., Kiefer, A. K., Drabant, E. M., Francke, U., Mountain, J. L., Goldman, S. M., Tanner, C. M., Langston, J. W., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002141 · Cited by 515 · see citing works

SREBPs: metabolic integrators in physiology and metabolism

Jeon, T.-I., & Osborne, T. F. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.10.004 · Cited by 513 · see citing works

Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease

Edwards, T. L., Scott, W. K., Almonte, C., Burt, A., Powell, E., Beecham, G., Wang, L.-Y., Züchner, S., Konidari, I., Wang, G., et al. (2010) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2009.00560.x · Cited by 512 · see citing works

Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease

Maraganore, D. M. (2006) · JAMA · doi:10.1001/jama.296.6.661 · Cited by 508 · see citing works

Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease

Murphy, K. E., Gysbers, A. M., Abbott, S. K., Tayebi, N., Kim, W. S., Sidransky, E., Cooper, A., Garner, B., & Halliday, G. M. (2014) · Brain · doi:10.1093/brain/awt367 · Cited by 475 · see citing works

Assembly-dependent endocytosis and clearance of extracellular a-synuclein

Lee, H.-J., Suk, J.-E., Bae, E.-J., Lee, J.-H., Paik, S. R., & Lee, S.-J. (2008) · The International Journal of Biochemistry &amp; Cell Biology · doi:10.1016/j.biocel.2008.01.017 · Cited by 470 · see citing works

Susceptibility to leprosy is associated with PARK2 and PACRG

Mira, M. T., Alcaïs, A., Thuc, N. V., Moraes, M. O., Flumeri, C. D., Thai, V. H., Phuong, M. C., Hương, N. T., Ba, N. N., Khoa, P. X., et al. (2004) · Nature · doi:10.1038/nature02326 · Cited by 467 · see citing works

Advances in the genetics of Parkinson disease

Trinh, J., & Farrer, M. J. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.132 · Cited by 465 · see citing works

Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration

Jang, H., Boltz, D., Sturm-Ramirez, K., Shepherd, K., Jiao, Y., Webster, R., & Smeyne, R. J. (2009) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0900096106 · Cited by 464 · see citing works

LRRK2 Inhibition Attenuates Microglial Inflammatory Responses

Moehle, M. S., Webber, P. J., Tse, T., Sukar, N., Standaert, D. G., DeSilva, T. M., Cowell, R. M., & West, A. B. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5601-11.2012 · Cited by 463 · see citing works

Neuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration

Gao, H., Kotzbauer, P. T., Uryu, K., Leight, S., Trojanowski, J. Q., & Lee, V. M. ‐. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0143-07.2008 · Cited by 435 · see citing works

A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies

Nalls, M. A., Durán, R., Lopez, G. J., Kurzawa‐Akanbi, M., McKeith, I. G., Chinnery, P. F., Morris, C. M., Theuns, J., Crosiers, D., Cras, P. P., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1925 · Cited by 434 · see citing works

LRRK2 Is Involved in the IFN-γ Response and Host Response to Pathogens

Gardet, A., Benita, Y., Li, C., Sands, B. E., Ballester, I., Stevens, C. R., Korzenik, J. R., Rioux, J. D., Daly, M. J., Xavier, R. J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000548 · Cited by 416 · see citing works

MHCII Is Required for -Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration

Harms, A. S., Cao, S., Rowse, A. L., Thome, A. D., Li, X., Mangieri, L. R., Cron, R. Q., Shacka, J. J., Raman, C., & Standaert, D. G. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5610-12.2013 · Cited by 406 · see citing works

Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration

Dehay, B., Ramı́rez, A., Martínez‐Vicente, M., Perier, C., Canron, M., Doudnikoff, É., Vital, A., Vila, M., Klein, C., & Bézard, E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112368109 · Cited by 381 · see citing works

Targeted Overexpression of Human α-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson Disease

Theodore, S., Cao, S., McLean, P. J., & Standaert, D. G. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818e5e99 · Cited by 367 · see citing works

Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease

Beilina, A., Rudenko, I. N., Kaganovich, A., Civiero, L., Chau, H., Kalia, S. K., Kalia, L. V., Lobbestael, E., Chia, R., Ndukwe, K., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318306111 · Cited by 351 · see citing works

Clearance and deposition of extracellular α-synuclein aggregates in microglia

Lee, H.-J., Suk, J.-E., Bae, E.-J., & Lee, S.-J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.045 · Cited by 343 · see citing works

A Deleterious Mutation in DNAJC6 Encoding the Neuronal-Specific Clathrin-Uncoating Co-Chaperone Auxilin, Is Associated with Juvenile Parkinsonism

Edvardson, S., Cinnamon, Y., Ta‐Shma, A., Shaag, A., Yim, Y.-I., Zenvirt, S., Jalas, C., Lesage, S., Brice, A., Taraboulos, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036458 · Cited by 318 · see citing works

Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects

Patsopoulos, N. A., Barcellos, L. F., Hintzen, R. Q., Schaefer, C., van Duijn, C. M., Noble, J. A., Raj, T., IMSGC, ANZgene, Gourraud, P.-A., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003926 · Cited by 312 · see citing works

Acid β‐glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α‐synuclein processing

Cullen, V., Sardi, S. P., Ng, J., Xu, Y., Sun, Y., Tomlinson, J. J., Kolodziej, P., Kahn, I. L., Säftig, P., Woulfe, J., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22400 · Cited by 303 · see citing works

Deficiency of ATP13A2 Leads to Lysosomal Dysfunction, α-Synuclein Accumulation, and Neurotoxicity

Usenovic, M., Tresse, E., Mazzulli, J. R., Taylor, J. P., & Krainc, D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5575-11.2012 · Cited by 291 · see citing works

α‐Synuclein contributes to GSK‐3β‐catalyzed Tau phosphorylation in Parkinson's disease models

Duka, T., Duka, V., Joyce, J. N., & Sidhu, A. (2009) · The FASEB Journal · doi:10.1096/fj.08-120410 · Cited by 276 · see citing works

Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice

Melrose, H. L., Dächsel, J. C., Behrouz, B., Lincoln, S. J., Yue, M., Hinkle, K. M., Kent, C., Korvatska, O., Taylor, J. P., Witten, L. M., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.07.010 · Cited by 273 · see citing works

Genetic Analysis of Pathways to Parkinson Disease

Hardy, J. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.014 · Cited by 270 · see citing works

CD38 and CD157: A long journey from activation markers to multifunctional molecules

Quarona, V., Zaccarello, G., Chillemi, A., Brunetti, E., Singh, V. K., Ferrero, E., Funaro, A., Horenstein, A. L., & Malavasi, F. (2013) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21092 · Cited by 269 · see citing works

Parkin Deficiency Increases Vulnerability to Inflammation-Related Nigral Degeneration

Frank-Cannon, T. C., Tran, T. A. T., Ruhn, K. A., Martinez, T. N., Hong, J. J., Marvin, M. A., Hartley, M., Treviño, I., O’Brien, D. E., Casey, B. H., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3001-08.2008 · Cited by 262 · see citing works

Genetic variability in the SNCA gene influences α‐synuclein levels in the blood and brain

Fuchs, J., Tichopád, A., Golub, Y., Munz, M., Schweitzer, K. J., Wolf, B., Berg, D., Mueller, J. C., & Gasser, T. (2007) · The FASEB Journal · doi:10.1096/fj.07-9348com · Cited by 247 · see citing works

Pervasive CpG suppression in animal mitochondrial genomes

Cardon, L. R., Burge, C., Clayton, D. A., & Karlin, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3799 · Cited by 238 · see citing works

Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy

Schapansky, J., Nardozzi, J. D., Felizia, F., & LaVoie, M. J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu138 · Cited by 226 · see citing works

Inflammation is genetically implicated in Parkinson’s disease

Dzamko, N., Geczy, C. L., & Halliday, G. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.028 · Cited by 222 · see citing works

Glucocerebrosidase and Parkinson disease: Recent advances

Schapira, A. H. V. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.03.013 · Cited by 220 · see citing works

The IkappaB Kinase Family Phosphorylates the Parkinson’s Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling

Dzamko, N. L., Iñesta-Vaquera, F., Zhang, J., Xie, C., Cai, H., Arthur, J. S. C., Tan, L., Choi, H., Gray, N. S., Cohen, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039132 · Cited by 215 · see citing works

Parkinsonism, Lrrk2 G2019S, and tau neuropathology

Rajput, A. H., Dickson, D. W., Robinson, C. A., Ross, O. A., Dächsel, J. C., Lincoln, S. J., Cobb, S. A., Rajput, M. L., & Farrer, M. J. (2006) · Neurology · doi:10.1212/01.wnl.0000240220.33950.0c · Cited by 210 · see citing works

Receptor-interacting protein (RIP) kinase family

Zhang, D., Lin, J., & Han, J. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.10 · Cited by 202 · see citing works

Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers

Mencacci, N. E., Isaias, I. U., Reich, M. M., Ganos, C., Plagnol, V., Polke, J. M., Brás, J., Hersheson, J., Stamelou, M., Pittman, A. M., et al. (2014) · Brain · doi:10.1093/brain/awu179 · Cited by 202 · see citing works

Tau protein: Relevance to Parkinson's disease

Lei, P., Ayton, S., Finkelstein, D. I., Adlard, P. A., Masters, C. L., & Bush, A. I. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.07.016 · Cited by 193 · see citing works

Lipopolysaccharide Animal Models for Parkinson's Disease

Liu, M., & Bing, G. (2011) · Parkinson s Disease · doi:10.4061/2011/327089 · Cited by 191 · see citing works

Association of Parkinson Disease with Structural and Regulatory Variants in the HLA Region

Wissemann, W. T., Hill-Burns, E. M., Zabetian, C. P., Factor, S. A., Patsopoulos, N., Hoglund, B., Holcomb, C., Donahue, R. J., Thomson, G., Erlich, H., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.10.009 · Cited by 189 · see citing works

Increased Mitochondrial Calcium Sensitivity and Abnormal Expression of Innate Immunity Genes Precede Dopaminergic Defects in Pink1-Deficient Mice

Akundi, R. S., Huang, Z., Eason, J., Pandya, J. D., Zhi, L., Cass, W. A., Sullivan, P. G., & Büeler, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016038 · Cited by 187 · see citing works

Genetics and genomics of Parkinson’s disease

Lin, M. K., & Farrer, M. J. (2014) · Genome Medicine · doi:10.1186/gm566 · Cited by 177 · see citing works

Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein

Béraud, D., Hathaway, H. A., Trecki, J., Chasovskikh, S., Johnson, D. A., Johnson, J. A., Federoff, H. J., Shimoji, M., Mhyre, T. R., & Maguire‐Zeiss, K. A. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9401-0 · Cited by 175 · see citing works

Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease

Noelker, C., Morel, L., Lescot, T., Osterloh, A., Alvarez-Fischer, D., Breloer, M., Henze, C., Depboylu, C., Skrzydelski, D., Michel, P. P., et al. (2013) · Scientific Reports · doi:10.1038/srep01393 · Cited by 164 · cited 1× · see citing works

PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity

Ramonet, D., Podhajska, A., Stafa, K., Sonnay, S., Trancikova, A. K., Tsika, E., Pletniková, O., Troncoso, J. C., Glauser, L., & Moore, D. J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr606 · Cited by 162 · see citing works

The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease

Durán, R., Mencacci, N. E., Angeli, A., Shoai, M., Deas, E., Houlden, H., Mehta, A. B., Hughes, D. A., Cox, T. M., Deegan, P. B., et al. (2012) · Movement Disorders · doi:10.1002/mds.25248 · Cited by 146 · see citing works

Development and Characterization of a New Parkinson's Disease Model Resulting from Impaired Autophagy

Ahmed, I., Liang, Y., Schools, S., Dawson, V. L., Dawson, T. M., & Savitt, J. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0209-12.2012 · Cited by 144 · see citing works

Phosphorylation of tau and α-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer’s disease, and in Parkinson’s disease and related α-synucleinopathies

Muntané, G., Dalfó, E., Martı́nez, A., & Ferrer, I. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.030 · Cited by 143 · see citing works

A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease

Holmans, P., Moskvina, V., Jones, L., Sharma, M., Vedernikov, A., Büchel, F., Sadd, M., Brás, J., Bettella, F., Nicolaou, N., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds492 · Cited by 139 · see citing works

A Direct Interaction between Leucine-rich Repeat Kinase 2 and Specific β-Tubulin Isoforms Regulates Tubulin Acetylation

Law, B. M. H., Spain, V. A., Leinster, V. H. L., Chia, R., Beilina, A. G., Cho, H. J., Taymans, J., Urban, M. K., Sancho, R. M., Ramírez, M. B., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.507913 · Cited by 135 · see citing works

Integration of GWAS SNPs and tissue specific expression profiling reveal discrete eQTLs for human traits in blood and brain

Hernandez, D. G., Nalls, M. A., Moore, M., Chong, S., Dillman, A., Trabzuni, D., Gibbs, J. R., Ryten, M., Arepalli, S., Weale, M. E., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.020 · Cited by 128 · see citing works

Association between Parkinson's disease and the HLA‐DRB1 locus

Ahmed, I., Tamouza, R., Delord, M., Krishnamoorthy, R., Tzourio, C., Mulot, C., Nacfer, M., Lambert, J., Beaune, P. H., Laurent‐Puig, P., et al. (2012) · Movement Disorders · doi:10.1002/mds.25035 · Cited by 120 · see citing works

MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease.

Kurkowska-Jastrzębska, I., Wrońska, A., Kohutnicka, M., Członkowski, A., & Członkowska, A. (1999) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-1999-1289 · Cited by 114 · see citing works

Alpha‐Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism

Duka, T., Rusnak, M., Drolet, R. E., Duka, V., Wersinger, C., Goudreau, J. L., & Sidhu, A. (2006) · The FASEB Journal · doi:10.1096/fj.06-6092com · Cited by 112 · see citing works

Lipopolysaccharide and Tumor Necrosis Factor Regulate Parkin Expression via Nuclear Factor-Kappa B

Tran, T. A. T., Nguyen, A. D., Chang, J., Goldberg, M. S., Lee, J., & Tansey, M. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023660 · Cited by 112 · see citing works

Expansion of the Parkinson disease-associated SNCA- Rep1 allele upregulates human α-synuclein in transgenic mouse brain

Cronin, K. D., Ge, D., Manninger, P., Linnertz, C. L., Rossoshek, A., Orrison, B. M., Bernard, D. J., El‐Agnaf, O. M. A., Schlossmacher, M. G., Nussbaum, R. L., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp265 · Cited by 109 · see citing works

LRRK2 phosphorylates novel tau epitopes and promotes tauopathy

Bailey, R. M., Covy, J. P., Melrose, H. L., Rousseau, L., Watkinson, R., Knight, J. A., Miles, S., Farrer, M. J., Dickson, D. W., Giasson, B. I., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1188-4 · Cited by 103 · see citing works

MEKK1 interacts with ?-actinin and localizes to stress fibers and focal adhesions

Christerson, L. B., Vanderbilt, C. A., & Cobb, M. H. (1999) · Cell Motility and the Cytoskeleton · doi:10.1002/(sici)1097-0169(1999)43:3 · Cited by 99 · see citing works

Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue

Overmyer, M., Helisalmi, S., Soininen, H., Laakso, M., Riekkinen Sr., P., & Alafuzoff, I. (1999) · Acta Neuropathologica · doi:10.1007/s004010051002 · Cited by 91 · see citing works

Genetic Regulation of α-Synuclein mRNA Expression in Various Human Brain Tissues

Linnertz, C. L., Saucier, L., Ge, D., Cronin, K. D., Burke, J. R., Browndyke, J. N., Hulette, C. M., Welsh-Bohmer, K. A., & Chiba‐Falek, O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007480 · Cited by 88 · see citing works

Peripheral Chemo-Cytokine Profiles in Alzheimers and Parkinsons Diseases

Reale, M., Greig, N., & Kamal, M. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709789055199 · Cited by 82 · see citing works

A mutation in SCARB2 is a modifier in gaucher disease

Velayati, A., DePaolo, J., Gupta, N., Choi, J. H., Moaven, N., Westbroek, W., Göker-Alpan, Ö., Goldin, E., Stubblefield, B. K., Kolodny, E. H., et al. (2011) · Human Mutation · doi:10.1002/humu.21566 · Cited by 81 · see citing works

High penetrance and pronounced variation in expressivity of GCH1 mutations in five families with dopa‐responsive dystonia

Steinberger, D., Weber, Y., Korinthenberg, R., Deuschl, G., Benecke, R., Martinius, J., & Müller, U. (1998) · Annals of Neurology · doi:10.1002/ana.410430512 · Cited by 77 · see citing works

Microglial activation in brain lesions with tau deposits: Comparison of human tauopathies and tau transgenic mice TgTauP301L

Sasaki, A., Kawarabayashi, T., Murakami, T., Matsubara, E., Ikeda, M., Hagiwara, H., Westaway, D. A., George‐Hyslop, P. S., Shoji, M., & Nakazato, Y. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.084 · Cited by 76 · see citing works

Genetic variants in Sporadic Parkinson's Disease: East vs West

Peeraully, T., & Tan, E. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70021-9 · Cited by 75 · see citing works

A novel human fibroblast growth factor treats experimental intestinal inflammation

Jeffers, M., McDonald, W. F., Chillakuru, R. A., Yang, M., Nakase, H., Deegler, L. L., Sylander, E. D., Rittman, B., Bendele, A. M., Sartor, R. B., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.36041 · Cited by 69 · see citing works

Leucine‐rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase‐3β

Kawakami, F., Shimada, N., Ohta, E., Kagiya, G., Kawashima, R., Maekawa, T., Maruyama, H., & Ichikawa, T. (2013) · FEBS Journal · doi:10.1111/febs.12579 · Cited by 67 · see citing works

Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease

Vandrovcová, J., Pittman, A. M., Malzer, E., Abou‐Sleiman, P. M., Lees, A. J., Wood, N. W., & de Silva, R. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.019 · Cited by 67 · see citing works

Evidence for More than One Parkinson's Disease-Associated Variant within the HLA Region

Hill‐Burns, E. M., Factor, S. A., Zabetian, C. P., Thomson, G. J., & Payami, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027109 · Cited by 66 · see citing works

PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices

Kim, J., Byun, J.-W., Choi, I., Kim, B., Jeong, H., Jou, I., & Joe, E.-H. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.1.38 · Cited by 66 · see citing works

Astrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons.

Saez, T. E., Pehar, M., Vargas, M. R., Barbeito, L., & Maccioni, R. B. (2004) · PubMed · Cited by 66 · see citing works

Variation in tau isoform expression in different brain regions and disease states

Majounie, E., Cross, W. C. H., Newsway, V., Dillman, A., Vandrovcová, J., Morris, C. M., Nalls, M. A., Ferrucci, L., Owen, M. J., O’Donovan, M. C., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.01.017 · Cited by 65 · see citing works

DDRGK1 Regulates NF-κB Activity by Modulating IκBα Stability

Peng, X., Ding, D., Zhou, J., Wang, M., & Cong, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064231 · Cited by 49 · see citing works

Overexpression of Ste20-Related Proline/Alanine-Rich Kinase Exacerbates Experimental Colitis in Mice

Yan, Y., Laroui, H., Ingersoll, S. A., Ayyadurai, S., Charania, M. A., Yang, S., Dalmasso, G., Obertone, T. S., Nguyen, H. T. T., Sitaraman, S. V., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002910 · Cited by 44 · see citing works

Induction of Matrix Metalloproteinase-3 (MMP-3) Expression in the Microglia by Lipopolysaccharide (LPS) via Upregulation of Glycoprotein Nonmetastatic Melanoma B (GPNMB) Expression

Shi, F., Duan, S., Cui, J., Yan, X., Li, H., Wang, Y., Chen, F., Zhang, L., Liu, J., & Xie, X. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0280-0 · Cited by 40 · see citing works

2.319 Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's Disease, and in Parkinson's disease and related alpha-synucleinopathies

Muntané, G., Dalfó, E., Martínez, A., & Ferrer, I. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70717-x · Cited by 40 · see citing works

Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson’s disease: A meta-analysis

Wu, X. L., Tang, K., Li, Y., Xiong, Y., Shen, L., Wei, Z., Zhou, K., Niu, J., Han, X., Yang, L., et al. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.04.013 · Cited by 38 · see citing works

Differential Co-Expression between α-Synuclein and IFN-γ Signaling Genes across Development and in Parkinson’s Disease

Liscovitch, N., & French, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115029 · Cited by 35 · see citing works

HLA Typing and Parkinson’s Disease

Lampe, J. B., Goßrau, G., Herting, B., Kempe, A., Sommer, U., Füssel, M., Weber, M., Koch, R., & Reichmann, H. (2003) · European Neurology · doi:10.1159/000072500 · Cited by 34 · see citing works

Association of TLR4 gene polymorphisms with sporadic Parkinson’s disease in a Han Chinese population

Zhao, J., Han, X., Li, X., Zhu, K., Liu, H., & Xie, A. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2227-9 · Cited by 32 · see citing works

Knockout of Ste20-Like Proline/Alanine-Rich Kinase (SPAK) Attenuates Intestinal Inflammation in Mice

Zhang, Y., Viennois, É., Xiao, B., Baker, M. T., Yang, S., Okoro, I., & Yan, Y. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.028 · Cited by 30 · see citing works

Parkinsonism in GTP cyclohydrolase 1 mutation carriers

Guella, I., Sherman, H. E., Appel‐Cresswell, S., Rajput, A. H., Rajput, A. H., & Farrer, M. J. (2014) · Brain · doi:10.1093/brain/awu341 · Cited by 25 · see citing works

Glucocerebrosidase, a new player changing the old rules in Lewy body diseases

Yang, N.-Y., Lee, Y.-N., Lee, H.-J., Kim, Y. S., & Lee, S. (2013) · Biological Chemistry · doi:10.1515/hsz-2012-0322 · Cited by 15 · see citing works

Microglia Function in the Central Nervous System During Health and Neurodegeneration

Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894 · see citing works

Selective neuronal vulnerability in Parkinson disease

Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,120 · see citing works

The SH-SY5Y cell line in Parkinson’s disease research: a systematic review

Xicoy, H., Wieringa, B., & Martens, G. J. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0149-0 · Cited by 1,036 · see citing works

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders · doi:10.1002/mds.27115 · Cited by 859 · see citing works

Parkinson's Disease Is Not Simply a Prion Disorder

Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1787-16.2017 · Cited by 186 · see citing works

LRRK2 at the interface of autophagosomes, endosomes and lysosomes

Roosen, D. A., & Cookson, M. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0140-1 · Cited by 182 · see citing works

NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s disease

von Herrmann, K. M., Salas, L. A., Martinez, E. M., Young, A. L., Howard, J. M., Feldman, M. S., Christensen, B. C., Wilkins, O. M., Lee, S., Hickey, W. F., et al. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0061-5 · Cited by 185 · see citing works

VPS35, the Retromer Complex and Parkinson’s Disease

Williams, E. T., Chen, X., & Moore, D. J. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-161020 · Cited by 173 · see citing works

Parkin and PINK1 functions in oxidative stress and neurodegeneration

Barodia, S. K., Creed, R. B., & Goldberg, M. S. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.12.004 · Cited by 168 · see citing works

Genetic and Environmental Factors in P arkinson's Disease Converge on Immune Function and Inflammation

Kline, E. M., Houser, M. C., Herrick, M. K., Seibler, P., Klein, C., West, A. B., & Tansey, M. G. (2020) · Movement Disorders · doi:10.1002/mds.28411 · Cited by 131 · see citing works

The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stress

Moloney, E. B., Moskites, A., Ferrari, E. J., Ole Isacson, A., & Hallett, P. J. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.08.013 · Cited by 128 · see citing works

Microglia in neurodegenerative diseases

Xu, Y., Jin, M.-Z., Yang, Z., & Jin, M.-Z. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.290881 · Cited by 118 · see citing works

Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson’s disease

Thomas, G. E. C., Zarkali, A., Ryten, M., Shmueli, K., Gil-Martínez, A. L., Leyland, L., McColgan, P., Acosta‐Cabronero, J., Lees, A. J., & Weil, R. S. (2021) · Brain · doi:10.1093/brain/awab084 · Cited by 112 · see citing works

Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease

Hallett, P. J., Engelender, S., & Ole Isacson, A. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1532-2 · Cited by 105 · see citing works

Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease

Surmeier, D. J., Halliday, G. M., & Simuni, T. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.001 · Cited by 99 · see citing works

Running wheel exercise reduces α-synuclein aggregation and improves motor and cognitive function in a transgenic mouse model of Parkinson's disease

Zhou, W., Barkow, J. C., & Freed, C. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0190160 · Cited by 90 · see citing works

Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of the mouse brain

Hallett, P. J., Huebecker, M., Brekk, O. R., Moloney, E. B., Rocha, E. M., Priestman, D. A., Platt, F. M., & Ole Isacson, A. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.02.028 · Cited by 85 · see citing works

Quantitative proteomic analysis of Parkin substrates in Drosophila neurons

Martinez, A., Lectez, B. L. P., Ramírez, J., Popp, O., Sutherland, J. D., Urbé, S., Dittmar, G., Clague, M. J., & Mayor, U. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0170-3 · Cited by 83 · see citing works

Auxilin Underlies Progressive Locomotor Deficits and Dopaminergic Neuron Loss in a Drosophila Model of Parkinson’s Disease

Li, S., He, Y., Ou, J., Zhao, Y., Li, R., Cheng, J., Lin, C., & Ho, M. S.-C. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.005 · Cited by 76 · see citing works

Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson’s Disease: Rationale for Clinical Trial, and Current Progress

Carroll, C., & Wyse, R. K. H. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-171203 · Cited by 73 · see citing works

Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson’s disease model

Parfitt, G. M., Coccia, E., Goldman, C., Whitney, K. R., Reyes, R., Sarrafha, L., Nam, K. H., Sohail, S., Jones, D. R., Crary, J. F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44732-2 · Cited by 70 · see citing works

DNAJC proteins and pathways to parkinsonism

Roosen, D. A., Blauwendraat, C., Cookson, M., & Lewis, P. A. (2019) · FEBS Journal · doi:10.1111/febs.14936 · Cited by 63 · see citing works

Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson’s Disease

Xicoy, H., Brouwers, J. F. H. M., Wieringa, B., & Martens, G. J. M. (2020) · Cells · doi:10.3390/cells9091966 · Cited by 62 · see citing works

Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease

Imbriani, P., Martella, G., Bonsi, P., & Pisani, A. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105851 · Cited by 61 · see citing works

LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives

Atashrazm, F., & Dzamko, N. L. (2016) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s102191 · Cited by 54 · see citing works

A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway

Salašová, A., Yokota, C., Potěšil, D., Zdráhal, Z., Bryja, V., & Arenas, E. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0193-9 · Cited by 51 · see citing works

Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson’s disease

Liu, H., Ho, P. W., Leung, G. C.-T., Lam, C. S.-C., Pang, S. Y.-Y., Li, L., Kung, M. H.-W., Ramsden, D. B., & Ho, S. (2017) · Scientific Reports · doi:10.1038/srep40887 · Cited by 51 · see citing works

Genetic Determinants of Parkinson's Disease: Can They Help to Stratify the Patients Based on the Underlying Molecular Defect?

Redenšek, S., Trošt, M., & Dolžan, V. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00020 · Cited by 48 · see citing works

Transgenic Overexpression of GPNMB Protects Against MPTP-Induced Neurodegeneration

Budge, K. M., Neal, M. P., Richardson, J. R., & Safadi, F. F. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01921-6 · Cited by 46 · see citing works

Microglial Turnover in Ageing-Related Neurodegeneration: Therapeutic Avenue to Intervene in Disease Progression

Azam, S., Haque, M. E., Kim, I., & Choi, D. (2021) · Cells · doi:10.3390/cells10010150 · Cited by 45 · see citing works

Targeting the cannabinoid CB 2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice

Palomo‐Garo, C., Gómez‐Gálvez, Y., García, C., & Fernández‐Ruíz, J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.04.004 · Cited by 44 · see citing works

The Presence of Alpha‐Synuclein in Skin from Melanoma and Patients with Parkinson's Disease

Rodríguez‐Leyva, I., Chi-Ahumada, É., Mejía, M., Castanedo-Cázares, J. P., Eng, W., Saikaly, S. K., Carrizales-Rodríguez, J., Levine, T., Norman, R. A., & Jiménez-Capdeville, M. E. (2017) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12494 · Cited by 41 · see citing works

Novel animal model defines genetic contributions for neuron-to-neuron transfer of α-synuclein

Tyson, T., Senchuk, M. M., Cooper, J. F., George, S., Raamsdonk, J. M. V., & Brundin, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-07383-6 · Cited by 43 · see citing works

Re-Cloning the N27 Dopamine Cell Line to Improve a Cell Culture Model of Parkinson's Disease

Gao, L., Zhou, W., Symmes, B. A., & Freed, C. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160847 · Cited by 42 · see citing works

Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease

Korecka, J., Moloney, E., Eggers, R., Hobo, B., Scheffer, S., Ras-Verloop, N., Pasterkamp, R., Swaab, D., Smit, A., van Kesteren, R. V., et al. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0084-17.2017 · Cited by 31 · see citing works

Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection

Pirooznia, S. K., Rosenthal, L. S., Dawson, V. L., & Dawson, T. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000189 · Cited by 36 · see citing works

DNA Damage and Parkinson’s Disease

Pfeifer, G. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084187 · Cited by 31 · see citing works

The SH-SY5Y cell line: a valuable tool for Parkinson’s disease drug discovery

Pandey, M., Karmakar, V., Majie, A., Dwivedi, M., Md, S., & Gorain, B. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2293158 · Cited by 30 · see citing works

Postsynaptic damage and microglial activation in AD patients could be linked CXCR4/CXCL12 expression levels

Sanfilippo, C., Castrogiovanni, P., Imbesi, R., Nunnari, G., & Rosa, M. D. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147127 · Cited by 29 · see citing works

Progranulin and GPNMB: interactions in endo-lysosome function and inflammation in neurodegenerative disease

Gillett, D. A., Wallings, R. L., Huarte, O. U., & Tansey, M. G. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02965-w · Cited by 30 · see citing works

Roles of mitophagy in cellular physiology and development

Dengjel, J., & Abeliovich, H. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2472-0 · Cited by 28 · see citing works

Brain CHID1 Expression Correlates with NRGN and CALB1 in Healthy Subjects and AD Patients

Castrogiovanni, P., Sanfilippo, C., Imbesi, R., Maugeri, G., Furno, D. L., Tibullo, D., Castorina, A., Musumeci, G., & Rosa, M. D. (2021) · Cells · doi:10.3390/cells10040882 · Cited by 28 · see citing works

The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research

Langston, R. G., Rudenko, I. N., & Cookson, M. (2016) · Biochemical Journal · doi:10.1042/bj20150985 · Cited by 27 · see citing works

Modeling Parkinson’s disease and treatment complications in rodents: Potentials and pitfalls of the current options

Francardo, V. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.014 · Cited by 28 · see citing works

The Changing Landscape of Parkinson Epidemiologic Research

Chen, H. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-171238 · Cited by 26 · see citing works

[Chronic blepharoconjunctivitis during a treatment with acitretin (Soriatane)].

Denis, P., Nordmann, J. –., Saïag, P., Liotet, S., Laroche, L., & Saraux, H. (1993) · PubMed · Cited by 27 · see citing works

CHI3L2 Expression Levels Are Correlated with AIF1, PECAM1, and CALB1 in the Brains of Alzheimer’s Disease Patients

Sanfilippo, C., Castrogiovanni, P., Imbesi, R., & Di Rosa, M. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01667-9 · Cited by 26 · see citing works

Genetic mutations linked to Parkinson's disease differentially control nucleolar activity in pre-symptomatic mouse models

Evsyukov, V., Domanskyi, A., Bierhoff, H., Gispert, S., Mustafa, R., Schlaudraff, F., Liss, B., & Parlato, R. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028092 · Cited by 26 · see citing works

Sex, Age, and Regional Differences in CHRM1 and CHRM3 Genes Expression Levels in the Human Brain Biopsies: Potential Targets for Alzheimer's Disease-related Sleep Disturbances

Sanfilippo, C., Giuliano, L., Castrogiovanni, P., Imbesi, R., Ulivieri, M., Fazio, F., Blennow, K., Zetterberg, H., & Rosa, M. D. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21666221207091209 · Cited by 20 · see citing works

Sex-Specific Transcriptome Differences in Substantia Nigra Tissue: A Meta-Analysis of Parkinson’s Disease Data

Mariani, E., Lombardini, L., Facchin, F., Pizzetti, F., Frabetti, F., Tarozzi, A., & Casadei, R. (2018) · Genes · doi:10.3390/genes9060275 · Cited by 25 · see citing works

Shared genetic etiology between Parkinson’s disease and blood levels of specific lipids

Xicoy, H., Klemann, C. J. H. M., Witte, W. D., Martens, M. B., Martens, G. J. M., & Poelmans, G. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00168-9 · Cited by 24 · see citing works

Parkinson's Disease: The Epidemiology, Risk Factors, Molecular Pathogenesis, Prevention, and Therapy

Guo, X., Song, D., Wu, M., Zhang, J., Li, J., & Yuan, L. (2025) · MedComm · doi:10.1002/mco2.70540 · Cited by 26 · see citing works

Shared molecular genetic factors influence subcortical brain morphometry and Parkinson’s disease risk

García‐Marín, L. M., Reyes‐Pérez, P., Díaz‐Torres, S., Medina-Rivera, A., Martin, N. G., Mitchell, B. L., & Rentería, M. E. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00515-y · Cited by 23 · see citing works

VPS35 and retromer dysfunction in Parkinson's disease

Rowlands, J., & Moore, D. J. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0384 · Cited by 22 · see citing works

Interplay between α-synuclein and parkin genes: Insights of Parkinson’s disease

Sharma, K., Chib, S., Gupta, A., Singh, R., & Chalotra, R. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09520-7 · Cited by 22 · see citing works

Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 2

Langston, R. G., Rudenko, I. N., Kumaran, R., Hauser, D. N., Kaganovich, A., Bonet‐Ponce, L., Mamais, A., Ndukwe, K., Dillman, A., Al-Saif, A. M., et al. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2650-4 · Cited by 19 · see citing works

Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson’s Disease Assessed by the Unified Parkinson’s Disease Rating Scale and the Hoehn–Yahr Stage

Shi, C., Zheng, Z., Wang, Q., Wang, C., Zhang, D., Zhang, M., Chan, P., & Wang, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155758 · Cited by 19 · see citing works

Differences in MTHFR and LRRK2 variant’s association with sporadic Parkinson’s disease in Mexican Mestizos correlated to Native American ancestry

Romero-Gutiérrez, E., Vázquez-Cárdenas, P., Moreno-Macías, H., Salas-Pacheco, J. M., Tusié‐Luna, T., & Arias-Carrión, Ó. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00157-y · Cited by 15 · see citing works

Mutations in Auxilin cause parkinsonism via impaired clathrin-mediated trafficking at the Golgi apparatus and synapsePreprint

Roosen, D. A., Landeck, N., Bonet‐Ponce, L., Kluss, J. H., Conti, M. M., Smith, N., Sáez-Atiénzar, S., Ding, J., Beilina, A. G., Kumaran, R., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/830802 · Cited by 15 · see citing works

The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson’s disease

Shen, Y., Guo, X., Han, C., Wan, F. J., Ma, K., Guo, S., Wang, L., Xia, Y. F., Liu, L., Lin, Z., et al. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2549-2 · Cited by 15 · see citing works

Cre‐dependent AAV vectors for highly targeted expression of disease‐related proteins and neurodegeneration in the substantia nigra

Grames, M. S., Dayton, R. D., Jackson, K. L., Richard, A. D., Lu, X., & Klein, R. L. (2018) · The FASEB Journal · doi:10.1096/fj.201701529rr · Cited by 13 · see citing works

Mitophagy as a stress response in mammalian cells and in respiring S. cerevisiae

Abeliovich, H., & Dengjel, J. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150278 · Cited by 11 · see citing works

Supramolecular organizing centers at the interface of inflammation and neurodegeneration

Sušjan, P., Ramuta, T. Ž., Boršić, E., Orehek, S., & Hafner‐Bratkovič, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940969 · Cited by 10 · see citing works

Increased copper toxicity in Saccharomyces cerevisiae lacking VPS35, a component of the retromer and monogenic Parkinson disease gene in humans

Sowada, N., Stiller, B., & Kubisch, C. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.157 · Cited by 10 · see citing works

Sex-dependent monoamine oxidase isoforms expression patterns during human brain ageing

Sanfilippo, C., Castrogiovanni, P., Imbesi, R., Lazzarino, G., Pietro, V. D., Volti, G. L., Tibullo, D., Barbagallo, I. A., Lazzarino, G., Avola, R., et al. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111516 · Cited by 8 · see citing works

CSF GPNMB in Parkinson's disease: A potential association with age and microglial activation

Zhu, X., Mizutani, Y., Ohdake, R., Tatebe, H., Maeda, T., Shima, S., Ueda, A., Ito, M., Ito, S., Tokuda, T., et al. (2024) · Journal of Parkinson s Disease · doi:10.1177/1877718x241288712 · Cited by 7 · see citing works

Parkinson’s disease

Cookson, M. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00007-5 · Cited by 7 · see citing works

Disease mechanisms as subtypes: Lysosomal dysfunction in the endolysosomal Parkinson's disease subtype

Mamais, A., Wallings, R. L., & Rocha, E. M. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00009-6 · Cited by 6 · see citing works

Rare VPS35 A320V Variant in Taiwanese Parkinson’s Disease Indicates Disrupted CI-MPR Sorting and Impaired Mitochondrial Morphology

Wu, Y., Lin, C., Chao, C., Chang, C.-W., Chen, C., & Lee‐Chen, G. (2020) · Brain Sciences · doi:10.3390/brainsci10110783 · Cited by 6 · see citing works

Movement Disorders and Inherited Metabolic Disorders

(2020) · Cambridge University Press eBooks · doi:10.1017/9781108556767 · Cited by 6 · see citing works

Proteomics; applications in familial Parkinson's disease

Li, Y., & Cookson, M. R. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14708 · Cited by 5 · see citing works

Genetic mechanisms underlying gray matter atrophy in Parkinson’s disease: a combined transcriptome and neuroimaging study

Ji, Y., Xu, M., Zhao, H., Cai, H., Chen, K., Zhang, L., Mao, H., Wang, F., Zhu, J., & Fang, X. (2025) · Cerebral Cortex · doi:10.1093/cercor/bhaf097 · Cited by 3 · see citing works

Burden of Parkinson’s disease in Iran: disparities, trends, and the impact of social development indicators

Sarmadi, M., Rezaei, M., Poursadeghiyan, M., Soltaninejad, M., Moradi, S., Ahangarzadeh, M., Mahdiabadi, M. Z., & Rahimi, S. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08206-7 · Cited by 3 · see citing works

Novel mGluR4 agonist Rapitalam ameliorates motor dysfunction in mice with tau-associated neurodegeneration

Avdeeva, N. V. (2020) · Research Results in Pharmacology · doi:10.3897/rrpharmacology.6.52098 · Cited by 3 · see citing works

Therapeutic Potential of α-Synuclein Evolvability for Autosomal Recessive Parkinson’s Disease

Wei, J., Ho, G. J., Takamatsu, Y., Masliah, E., & Hashimoto, M. (2021) · Parkinson s Disease · doi:10.1155/2021/6318067 · Cited by 3 · see citing works

Plasticity-Induced Motor Recovery of Bilateral Intermittent Theta Burst Stimulation in Parkinson’s Disease: A Randomized, Double-Blind, Sham-Controlled, Crossover Trial

Rashid-López, R., Macías-García, P., Cruz-Gómez, Á. J., Cano-Cano, F., Sánchez-Fernández, F. L., Sarrias-Arrabal, E., del Marco, À., González-Moraleda, Á., Lozano-Soto, E., Sanmartino, F., et al. (2025) · Neurology and Therapy · doi:10.1007/s40120-025-00865-0 · Cited by 1 · see citing works

Parkinson’s Disease in Humans and in Nonhuman Primate Aging and Neurotoxin Models

Metzger, J. M., Jones, C. A., & Emborg, M. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00046-4 · Cited by 1 · see citing works

Living Between Sickness and Health: Where Is the Human Genome Leading Us?

Broadwater, A., & Pathak, Y. V. (2018) · Springer eBooks · doi:10.1007/978-981-10-7506-3_2

Natural and Synthetic GHSR1a Agonists as Neuroprotective Agents in Models of Parkinson's disease

Rees, D. J. (2017) · doi:10.23889/suthesis.40946

Genetic mechanisms underlying gray matter atrophy in Parkinson’s disease: a combined transcriptome and neuroimaging studyPreprint

Fang, X., Ji, Y., Xu, M., Zhao, H., Cai, H., Chen, K., Zhang, L., Mao, H., Wang, F., & Zhu, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3581690/v1

Histone Acetylation Contributes to Mitochondrial Dysfunction and Neuroinflammation in Parkinson's disease

Huang, M. (2022) · doi:10.31274/td-20240329-388

Unprecedented prospects as forthcoming drug targets: New boulevard in the cure and treatment of neurodegenerative disorders

Karati, D., Mukherjee, S., & Batabyal, N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95735-9.00013-9

Cutaneous α-Synuclein and Age Spots in Neurodegeneration: A Systematic Review and Testable Hypothesis

Stadio, A. D., Luca, P. D., Francavilla, B., Ralli, M., Girolamo, S. D., Indovina, I., Ciccarese, G., & Dipietro, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010096

Glycoprotein Non‐Metastatic Melanoma Protein B ( GPNMB ): A Translational Pharmacodynamic Biomarker for PIKfyve Inhibition With VRG50635

Gontier, G., Kim, G., Wang, C., Zhu, K., Gau, R., Zhang, N., Naphade, S. B., Stewart, A. J., Schmidt, M. J., Galemmo, R., et al. (2026) · Clinical and Translational Science · doi:10.1111/cts.70489

GPNMB and glycosphingolipid measurements in cerebrospinal fluid and plasma from Parkinson’s disease patientsPreprint

Fernández‐Suárez, M. E., Bush, R., Biase, E. D., Vruchte, D. T., Priestman, D. A., Cortina‐Borja, M., Cooper, O., Hardy, J., Hallett, P. J., Ole Isacson, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.09.712000

Dopaminergic neuronal dysfunction induced by newer generation systemic insecticides in Caenorhabditis elegansPreprint

Filipowicz, A. R., Bui, K., Osman, N., Morton, K. S., Kenny-Ganzert, I. W., Sherwood, D. R., Meyer, J. N., & Allard, P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.14.732178

Parkinson’s Disease and Other Synucleinopathies

Cookson, M. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00006-7

Genetics and genomics of Parkinson’s disease

Lin, M. K., & Farrer, M. J. (2014) · Genome Medicine · doi:10.1186/gm566 · Cited by 177 · see citing works

Clinical Manifestations and Molecular Backgrounds of Parkinson's Disease Regarding Genes Identified From Familial and Population Studies

Nishioka, K., Imai, Y., Yoshino, H., Li, Y., Funayama, M., & Hattori, N. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.764917 · Cited by 17 · see citing works

Parkinson’s Disease Genetic Risk Evaluation in Microglia Highlights Autophagy and Lysosomal GenesPreprint

Booms, A., Pierce, S. E., & Coetzee, G. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.17.254276 · Cited by 7 · see citing works

A Tangled Web – Tau and Sporadic Parkinson's Disease

Wray, S., & Lewis, P. A. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00150 · Cited by 31 · see citing works